Navigation Links
The Pershing Square Foundation Partners with The Sohn Conference Foundation To Launch $25 Million Cancer Research Alliance
Date:10/22/2013

NEW YORK, Oct. 22, 2013 /PRNewswire/ -- The Pershing Square Foundation and The Sohn Conference Foundation are pleased to announce the launch of the Pershing Square Sohn Cancer Research Alliance today at the Annual Galien Forum in New York. The Alliance is dedicated to accelerating cures for cancer by advancing the pursuit of innovative cancer research and by facilitating partnerships between the science and business communities.

The Pershing Square Sohn Prize for Young Investigators in Cancer Research will be the first initiative of the Alliance and will provide New York City-based scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking.  Prize winners will each receive a stipend of $200,000 per year for up to three years. The Alliance will also provide a $1 million grant to the Sohn Conference Foundation to support the Damon Runyon-Sohn Pediatric Cancer Fellowship.

"The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer," said Bill Ackman, co-founder of The Pershing Square Foundation and CEO of Pershing Square Capital Management, L.P. "The Pershing Square Sohn Cancer Research Alliance will enable innovators to find cures that benefit society.  This is especially critical now as the scientific research community faces the most drastic federal defunding in decades."

"The Pershing Square Foundation and the Sohn Conference Foundation are two of our city's leading philanthropies committed to helping people live healthier and more fulfilling lives," said Mayor Michael R. Bloomberg. "This pioneering new effort to foster and reward scientific innovation will accelerate the advancement of one of our city's fastest-growing industries – the commercial life sciences. That's going to make New York City even more of a world leader in this flourishing and critically important area of research."

The Pershing Square Sohn Cancer Research Prize will also serve as a catalyst for collaboration among scientists, academics, nonprofits, business investors, and the biotech and pharmaceutical industries.  The program seeks to guide philanthropic funds to feed critical scientific discoveries, attracting like-minded investors to the cause of fighting cancer and creating a pipeline for early-stage biomedical investments. Winners will present their most innovative and promising work to an audience of sophisticated investors at the Sohn Conference during its annual meeting in May.  

"It is critically important to fund and guide young scientists so they can make groundbreaking discoveries. The Pershing Square Sohn Prize will play a catalytic role in bridging the gap between academia and the pharmaceutical industry, creating a culture of entrepreneurs for cures," said Marc Tessier-Lavigne, Ph.D., President of The Rockefeller University.

Evan Sohn, Vice President of the Sohn Conference Foundation, said:  "This partnership will foster, recognize and reward excellence in scientific innovation to prevent, treat and cure all cancers, ranging from adult to pediatric."

The Alliance is proud to rely on the guidance of a highly accomplished advisory board including:  Marc Tessier-Lavigne, Ph.D., President, Rockefeller University; Craig Thompson, M.D., President and CEO, Memorial Sloan-Kettering Cancer Center; Bruce Stillman, Ph.D., President and CEO, Cold Spring Harbor Laboratory; Siddharta Muckerjee, M.D., Assistant Professor, Department of Medicine, Division of Oncology, Columbia University Medical Center; Mikael Dolsten, M.D., Ph.D., President, Worldwide Research and Development, Pfizer, Inc.; Allan Goodman, Ph.D., President and CEO of the Institute of International Education; and Pablo Legorreta, Founder and Chief Executive Officer of Royalty Pharma.

Olivia Tournay Flatto, Ph.D. is the Executive Director of the Pershing Square Sohn Cancer Research Alliance and leads the Pershing Square Sohn Prize.  She said:  "Bold, innovative projects need funding at the earliest stages, and this Alliance will break down the barriers between the scientific and business communities."

About The Pershing Square Foundation

The Pershing Square Foundation, based in New York, was founded in December 2006 by Karen and Bill Ackman. Bill is the CEO and Portfolio Manager of Pershing Square Capital Management, L.P. The Pershing Square Foundation has committed $225 million in grants and social investments to support exceptional leaders and innovative organizations that tackle important social issues and deliver scalable and sustainable impact.

About The Sohn Conference Foundation

The Sohn Conference Foundation is dedicated to supporting innovative initiatives to cure and treat pediatric cancer. Identifying specific areas of need, the Foundation funds groundbreaking research, state-of-the-art technology, and programs to target cures and improve patient care.


'/>"/>
SOURCE The Pershing Square Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
2. 81,200 Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Pharmaceuticals And BioMed Realty
3. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
4. BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street
5. American Academy of Family Physicians Foundation Launches Cities for Life
6. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
7. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
8. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
9. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
10. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
11. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... -- Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation clinic, ... . The reputable clinic will continue to be co-owned and ... staff of four clinicians. Lipkin received his doctorate in physical ... years of experience with a strong background in manual therapy. ... 10th PRN clinic in and around the Denver ...
(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...
(Date:8/7/2017)... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ...  All comparisons, unless otherwise noted, are to the quarter ended ... Second Quarter 2017 Highlights include: Revenue ... 3.5% Total prescriptions dispensed of 220,000, compared ... 7.6% Gross profit per prescription dispensed ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... 2017 , ... “Three Narrow Roads”: a vivid and provocative look into the ... Dr. Burnett King Sr., is currently the pastor-teacher-visionary at Simply the WORD Church, a ... Inc., a track-and-field program geared towards youth. , King shares, “When I take time ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin Care ... skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “We ...
(Date:8/18/2017)... ... ... the Snake”: an entertaining and moral-based short story about an unkind snake learning a ... Jr., a husband, father and grandfather who served as a U.S. Marine, U.S. Army ... for children and teens. My goal is to teach kids to use good judgement ...
(Date:8/17/2017)... Mass (PRWEB) , ... August 17, 2017 , ... ... use by health care organizations and considered extremely effective, very effective, or effective ... Physicians and Physician Leadership”. , NEJM Catalyst Insights Reports are based on surveys ...
(Date:8/17/2017)... ... August 17, 2017 , ... Industry CEOs, life ... for Anti-Infectives Rx. This off-the-record networking forum of the Boston Biotech Conference series ... School. , Industry leaders and decision makers will discuss issues facing the development ...
Breaking Medicine News(10 mins):